2,4,6,8,10,12,14,16-Heptadecaoctaen-1-ol,2,6,11,15-tetramethyl-17-[(1R)-2,6,6-trimethyl-2-cyclohexen-1-yl]-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI) (43126-13-2)

Identification
Name:	2,4,6,8,10,12,14,16-Heptadecaoctaen-1-ol,2,6,11,15-tetramethyl-17-[(1R)-2,6,6-trimethyl-2-cyclohexen-1-yl]-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
Synonyms:	8'-Apo-e,y-carotenol, (6R)-
CAS:	43126-13-2
Molecular Formula:	C30H42 O
Molecular Weight:	418.6539
InChI:	InChI=1/C30H42O/c1-24(13-8-9-14-25(2)16-11-18-27(4)23-31)15-10-17-26(3)20-21-29-28(5)19-12-22-30(29,6)7/h8-11,13-18,20-21,31H,12,19,22-23H2,1-7H3/b9-8+,15-10+,16-11+,21-20+,24-13+,25-14+,26-17+,27-18+
Molecular Structure:
Properties
Flash Point:	172.3°C
Boiling Point:	575.4°C at 760 mmHg
Density:	0.953g/cm³
Refractive index:	1.558
Flash Point:	172.3°C
Safety Data

Other Product

2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid,17-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-2,6,11,15-tetramethyl-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
2,4,6,8,10,12,14,16-Heptadecaoctaen-1-ol,2,6,11,15-tetramethyl-17-(2,3,4-trimethylphenyl)-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
2,4,6,8,10,12,14,16-Octadecaoctaen-1-one,17-[(2S,6S,7aR)-2,4,5,6,7,7a-hexahydro-6-hydroxy-4,4,7a-trimethyl-2-benzofuranyl]-1-[(1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13-trimethyl-,(2E,4E,6E,8E,10E,12E,14E,16E)-
2,4,6,8,10,12,14,16-Heptadecaoctaenal,2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E,14E,16E)-
2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E,14E,16E)-
2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, ethylester, (2E,4E,6E,8E,10E,12E,14E,16E)-
2,4,8,10,12,14-Pentadecahexaen-6-ynal,4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,8E,10E,12E,14E)-
2,4,6,8,10,12,14-Heptadecaheptaen-16-ynal,17- [(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexen- 1-yl]-2,6,11,15-tetramethyl-,(2E,4E,- 6E,8E,10E,12E,14E)-
2,4,6,8,10,12,14,16,18-Nonadecanonaenal,19-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl]-4,8,13,17-tetramethyl-,(2E,4E,6E,8E,10E,12E,14E,16E,18E)-
2,4,6,8,10,12,14,16,18,20,22-Tricosaundecaenal,23-(4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-4,8,12,17,21-pentamethyl-,(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)- (9CI)
2,4,6,8,10,12,14,16,18-Nonadecanonaenoic acid,4,8,13,17-tetramethyl-19-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, methylester, (2E,4E,6E,8E,10E,12E,14E,16E,18E)-
2,4,6,8,10,12,14,16,18-Nonadecanonaenoic acid,4,8,13,17-tetramethyl-19-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E,14E,16E,18E)-
2,4,6,8,10,12,14-Pentadecaheptaenal,4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E,14E)-
4,6,8,10,12,14,16,18,22-Tetracosanonaen-2-ol,2,6,10,15,19,23-hexamethyl-, (4E,6E,8E,10E,12E,14E,16E,18E)-
b-D-Glucopyranose, 1-[hydrogen(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate],6'-ester with 2-b-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one(9CI)
4,6,8,10,12,14,16,18,20,22,24,26,30-Dotriacontatridecaen-2-ol,2,6,10,14,19,23,27,31-octamethyl-3-(3-methyl-2-buten-1-yl)-, (3S,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-
(4E)-3,5,5-trimethyl-4-[(2E,4E,6E,8E,10E,12E,14E,16E,18E)-3,7,12,16-te tramethyl-18-(2,6,6-trimethyl-4-oxo-1-cyclohex-2-enylidene)octadeca-2, 4,6,8,10,12,14,16-octaenylidene]cyclohex-2-en-1-one
2,4,6,8,10,12,14,16-Heptadecaoctaenal,2,6,11,15-tetramethyl-17-(2,3,4-trimethylphenyl)-,(2E,4E,6E,8E,10E,12E,14E,16E)-
2,4,6,8,10,12,14,16,18,20-Heneicosadecaenoicacid, 2,6,10,15,19-pentamethyl-21-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E)-
L-Glutamic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)